Item | Information |
---|---|
CAS RN | 74-93-1 |
Chemical Name | Methyl mercaptan (Methanethiol) |
Substance ID | H26-B-104, R-047 |
Classification year (FY) | FY2014 |
Ministry who conducted the classification | Ministry of Health, Labour and Welfare (MHLW)/Ministry of the Environment (MOE) |
New/Revised | Revised |
Classification result in other fiscal year | FY2006 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | GHS Classification Guidance for the Japanese Government (FY2013 revised edition) |
UN GHS document (External link) | UN GHS document |
Definitions/Abbreviations (Excel file) | Definitions/Abbreviations |
Model Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Model SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | eChemPortal |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
1 | Explosives | Not applicable |
- |
- | - | Gas (GHS definition) |
2 | Flammable gases (including chemically unstable gases) | Category 1 |
Danger |
H220 |
P210
P377 P381 P403 |
It was classified in Category 1 from an explosion limit (3.9-21.8% (ICSC (2003))). Besides, it is classified in Division 2.3, Subsidiary Risk 2.1 (UN1064) in UNRTDG. |
3 | Aerosols | Not applicable |
- |
- | - | Not aerosol products. |
4 | Oxidizing gases | Not classified |
- |
- | - | Flammable gas classified in Division 2.3, Subsidiary Risk 2.1 (UN1064) in UNRTDG. |
5 | Gases under pressure | Liquefied gas |
Warning |
H280 | P410+P403 | From a critical temperature (196.8 deg C (HSDB (Access on September 2014))) above +65 deg C, it was classified as liquefied gas (low pressure liquefied gas). |
6 | Flammable liquids | Not applicable |
- |
- | - | Gas (GHS definition) |
7 | Flammable solids | Not applicable |
- |
- | - | Gas (GHS definition) |
8 | Self-reactive substances and mixtures | Not applicable |
- |
- | - | Gas (GHS definition) |
9 | Pyrophoric liquids | Not applicable |
- |
- | - | Gas (GHS definition) |
10 | Pyrophoric solids | Not applicable |
- |
- | - | Gas (GHS definition) |
11 | Self-heating substances and mixtures | Not applicable |
- |
- | - | Gas (GHS definition) |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Not applicable |
- |
- | - | Gas (GHS definition) |
13 | Oxidizing liquids | Not applicable |
- |
- | - | Gas (GHS definition) |
14 | Oxidizing solids | Not applicable |
- |
- | - | Gas (GHS definition) |
15 | Organic peroxides | Not applicable |
- |
- | - | Gas (GHS definition) |
16 | Corrosive to metals | Classification not possible |
- |
- | - | Test methods applicable to gas substances are not available. |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Not applicable |
- |
- | - | Gas (GHS definition) |
1 | Acute toxicity (Dermal) | Not applicable |
- |
- | - | Gas (GHS definition) |
1 | Acute toxicity (Inhalation: Gases) | Category 3 |
Danger |
H331 |
P304+P340
P403+P233 P261 P271 P311 P321 P405 P501 |
Based on a report of an LC50 value of 675 ppm for rats (PATTY (6th, 2012), SIDS (2009), ACGIH (7th, 2004), DFGOT Vol. 20 (2003), ATSDR (1992)), it was classified in Category 3. Besides, according to the GHS Classification Guidance for the Japanese Government, by giving priority to an LC50 value (4 hours), the reference value in units of ppm was applied. |
1 | Acute toxicity (Inhalation: Vapours) | Not applicable |
- |
- | - | Gas (GHS definition) |
1 | Acute toxicity (Inhalation: Dusts and mists) | Not applicable |
- |
- | - | Gas (GHS definition) |
2 | Skin corrosion/irritation | Category 2 |
Warning |
H315 |
P302+P352
P332+P313 P362+P364 P264 P280 P321 |
Although there were no concrete data, based on a description that this substance was irritating to the skin (HSDB (Access on September 2014)), it was classified in Category 2. New information, HSDB (Access on September 2014) was added, and the category was changed. |
3 | Serious eye damage/eye irritation | Category 2 |
Warning |
H319 |
P305+P351+P338
P337+P313 P264 P280 |
There are reports that mucosa irritation was observed by exposure of rats to this substance (ACGIH (7th, 2004)), and that mucosa irritation was observed as the effect by exposure of humans (ACGIH (7th, 2004)). In addition, there is a description that this substance was irritating to the eyes (HSDB (Access on September 2014)). From the above results, it was classified in Category 2. |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
4 | Skin sensitization | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
5 | Germ cell mutagenicity | Classification not possible |
- |
- | - | The substance was classified as "Classification not possible" because it was not possible to classify a substance as "Not classified" according to the revised GHS classification guidance for the Japanese government. As for in vivo, it was negative in mouse bone marrow micronucleus tests (SIDS (2009), ACGIH (2004), DFGOT Vol. 20 (2003)). As for in vitro, it was negative in a bacterial reverse mutation test (IUCLID (2000)). |
6 | Carcinogenicity | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
7 | Reproductive toxicity | Classification not possible |
- |
- | - | There is a report that, in a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (TG 422) in which rats were exposed to the sodium salt of this substance (methyl mercaptan sodium salt) through the oral route (gavage), neither reproductive toxicity nor developmental toxicity was observed (SIDS (2009)). However, since it was a screening test, it was classified as "Classification not possible." |
8 | Specific target organ toxicity - Single exposure | Category 1 (central nervous system, respiratory organs, haemal system), Category 3 (narcotic effects) |
Danger Warning |
H370
H336 |
P308+P311
P260 P264 P270 P321 P405 P501 P304+P340 P403+P233 P261 P271 P312 |
This substance was irritating to the respiratory tract (DFGOT Vol. 20 (2003), PATTY (6th, 2012), HSDB (Access on September 2014)). In humans, in cases such as inhalation exposure of workers, cough, headache, dizziness, staggering gait, nausea, vomiting, chest tightness, wheezing, tachypnea, respiratory insufficiency, coma, inflammation in the nasal mucosa and lung, pulmonary edema, methemoglobinemia, cyanosis, acute hemolytic anemia, muscular weakness, convulsions, diplopia, central nervous system depression, paralysis of skeletal and respiratory muscles were observed (DFGOT Vol. 20 (2003), PATTY (6th, 2012), ATSDR (1992), HSDB (Access on September 2014)). As for experimental animals, there were reports of narcotic effects, lethargy, gait difficulty, tremors, loss of righting reflex, tachypnea, respiratory depression, dyspnea, coma, muscular weakness, convulsions, paralysis of skeletal and respiratory muscles, cyanosis, inflammation in the nasal mucosa and lung, pulmonary edema within the range of 1.33-3.31 mg/L by inhalation exposure (SIDS (2009), ACGIH (7th, 2004), DFGOT Vol. 20 (2003), PATTY (6th, 2012), ATSDR (1992), HSDB (Access on September 2014)). Effects on the central nervous system, respiratory organs and blood system were observed in human findings, and effects on the respiratory organs and central nervous system were observed in experimental animals at doses within the guidance value range of Category 1. From the above, it was classified in Category 1 (central nervous system, respiratory organs, blood system), Category 3 (narcotic effects). |
9 | Specific target organ toxicity - Repeated exposure | Category 1 (central nervous system, respiratory organs) |
Danger |
H372 |
P260
P264 P270 P314 P501 |
In humans, there is a description that irritation of the eye and nasal mucosa, headache, nausea, vomiting, breathing difficulties, and impaired heme synthesis were observed as effects not by the effect of a sole exposure of this substance, but by long-term combined exposure with other sulfuric compounds such as dimethyl sulfide (DFGOT vol. 20 (2003)). In addition, there is a description that this substance was a central nervous system depressant and acted like hydrogen sulfide on the respiratory center producing death by respiratory paralysis (PATTY (6th, 2012)). As for experimental animals, in a test in which rats were exposed to this substance (estimated as the gas) at concentrations up to 57 ppm by inhalation for 3 months, although a change in behavior during exposures (crowding together with upturned noses) was observed at or above 2 ppm, and it was notably observed with decreased body weight gain in the 57 ppm group, no toxicities indicative of target organs were detected (SIDS (2009), ACGIH (2004), DFGOT vol. 20 (2003), PATTY (6th, 2012)). Although this study did not cover the concentrations within the guidance value range of Category 2 to be possible to determine the overall toxicity of this substance through the inhalation route, it is considered that the change in behavior with the upturned noses, observed during exposures, was due to nasal irritation (DFGOT vol. 20 (2003)). As above, based on the findings in humans, it was classified in Category 1 (central nervous system, respiratory organs). Besides, although there is a description that, in a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test in which rats were dosed the sodium salt of this substance (CAS RN: 5188-07-8) by gavage for 8-9 weeks, at 45 mg/kg/day (converted guidance value: ca. 29.4 mg/kg/day (Category 2)) of the maximum dose, clinical symptoms considered due to central nerve depression (hypotonia, ataxia) and effects on the hemal system (decreased erythrocyte counts, reduced hemoglobin concentration and hematocrit value, etc.) were observed, and secondary effects associated with anemia (extramedullary hematopoiesis, hemosiderin deposition) were observed in the spleen or the liver (SIDS (2009)), this substance is gaseous, and there was lack of findings to support effects on the blood system in the hazardous information through the inhalation route. Therefore, "the blood system" was not adopted as the target organ. |
10 | Aspiration hazard | Not applicable |
- |
- | - | Gas (GHS definition) |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment (Acute) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
11 | Hazardous to the aquatic environment (Long-term) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
12 | Hazardous to the ozone layer | Classification not possible |
- |
- | - | This substance is not listed in the Annexes to the Montreal Protocol. |
|